_version_ |
1828105879404150784
|
collection |
DOAJ
|
first_indexed |
2024-04-11T10:08:49Z
|
format |
Article
|
id |
doaj.art-d59bfa25bc6e4f84bc90aa6c8faada40
|
institution |
Directory Open Access Journal
|
issn |
1932-6203
|
language |
English
|
last_indexed |
2024-04-11T10:08:49Z
|
publishDate |
2013-01-01
|
publisher |
Public Library of Science (PLoS)
|
record_format |
Article
|
series |
PLoS ONE
|
spelling |
doaj.art-d59bfa25bc6e4f84bc90aa6c8faada402022-12-22T04:30:09ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0187Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomeshttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762986/?tool=EBI
|
spellingShingle |
Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
PLoS ONE
|
title |
Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
|
title_full |
Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
|
title_fullStr |
Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
|
title_full_unstemmed |
Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
|
title_short |
Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
|
title_sort |
correction the cytokine release inhibitory drug crid3 targets asc oligomerisation in the nlrp3 and aim2 inflammasomes
|
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3762986/?tool=EBI
|